The reworked CPAP and BiPAP machines from Philips Respironics were found to be “unlikely to result in an appreciable harm to health in patients,” Philips said Dec. 21.
Valencia, Calif.-based Advanced Biologics has agreed to pay over $12 million for allegedly violating the False Claims Act by misleading federal programs regarding radio-frequency emissions generated by cochlear implants, according to a Dec. 20 report f…
From a purchase cap on pediatric medications to new flu treatment protocol, here are 13 supply chain updates for ASC leaders to know reported by Becker’s since Dec. 13:
After more than two years of disruptions and high demand, supply chain leaders are taking the lessons learned in the COVID-19 pandemic to strengthen their supply chain in hopes of preventing issues from resurfacing.
People are the focus of supply chain decisions for Jacquelyn Marcus, vice president for supply chain management at NYU Langone Health in New York City.
To ensure Houston-based MD Anderson, the nation’s largest transfusing hospital, has enough blood, its donor operations team pivoted to solutions such as more double red cell donations and outreach.
Medical device company Coloplast agreed to settle a U.S. lawsuit for $14.5 million after it self-reported a failure to offer contractual discounts and documented incorrect countries of origin for some products.
Burton Fuller, chief supply chain officer at Baltimore-based Johns Hopkins Health System, found himself unable to decide between a career in medicine or business. It was not until he started his first consulting job in hospital supply that he realized …
Case numbers have long recovered since the onset of the COVID-19 pandemic, but ASC leaders are still struggling with supply costs as they compete for contracts with the deep pockets of hospitals and health systems.